Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1985-01-04
1990-08-28
Lee, Lester L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 13, 514 14, 514 15, 530324, 530325, 530326, A61K 3702, C07K 706, C07K 708, C07K 710
Patent
active
049525611
ABSTRACT:
A DNA fragment encoding at least part of the ANF protein has been molecularly cloned and its nucleotide sequence partially determined. The composition and sequence of a peptide containing 116 amino acids within the ANF gene have been determined. Biologically active subunit peptides have been identified.
REFERENCES:
patent: 4059694 (1977-11-01), Norton et al.
patent: 4103004 (1978-07-01), Norton et al.
patent: 4496544 (1985-01-01), Needleman
patent: 4508712 (1985-04-01), Needleman
Scolnick Edward M.
Zivin Robert A.
Caruso Charles M.
Lee Lester L.
Merck & Co. , Inc.
Perrella Donald J.
Pfeiffer Hesna J.
LandOfFree
Cardiac atrial peptides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cardiac atrial peptides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cardiac atrial peptides will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1589917